Pain Management Techniques for ACL Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the effectiveness of two pain management methods for individuals undergoing ACL (anterior cruciate ligament) surgery. One group will receive an adductor canal nerve block, while the other will not. Researchers seek to determine if both methods offer the same level of pain control during and after surgery. The trial is suitable for adults aged 18 to 45 who require ACL surgery. As an unphased trial, it provides participants the chance to contribute to valuable research that could enhance pain management strategies for future patients.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these pain management techniques are safe for ACL surgery?
Research has shown that the adductor canal nerve block is a common method for managing pain after ACL surgery. One study found it reduces pain after knee surgeries with fewer side effects compared to other nerve blocks, such as the femoral nerve block. This approach may result in less muscle weakness, which is beneficial for patients.
Another study measured pain levels at various times after surgery using a pain score. The results indicated that patients who received the adductor canal nerve block reported manageable pain levels within the first three days, suggesting the block is generally well-tolerated.
Overall, research suggests that the adductor canal nerve block is a safe option for managing pain after ACL surgery, with few reports of serious issues.12345Why are researchers excited about this trial?
Researchers are excited about the adductor canal nerve block technique for ACL surgery pain management because it offers a targeted approach to numbing the nerves that supply sensation to the knee. Unlike standard methods like general anesthesia or other nerve blocks that affect larger areas, this technique focuses specifically on the adductor canal, potentially reducing side effects like muscle weakness. Additionally, it uses ropivacaine, which is known for its long-lasting effect, providing extended pain relief post-surgery. By minimizing pain more precisely, this method could enhance recovery and improve overall patient comfort.
What evidence suggests that these pain management techniques could be effective for ACL surgery?
Research has shown that the adductor canal nerve block (ACB), which participants in this trial may receive, effectively manages pain after ACL surgery. Studies comparing ACB to other methods have found it equally effective for pain control. One study found that ACB provides pain relief similar to the femoral nerve block. These findings suggest that ACB is a reliable choice for reducing pain after ACL reconstruction.678910
Who Is on the Research Team?
Cassandra Lee, MD
Principal Investigator
UC-Davis Health
Are You a Good Fit for This Trial?
This trial is for adults aged 18-45 who have confirmed ACL tears and are recommended to undergo reconstructive surgery. It's not suitable for those unable to consent, pregnant women, individuals with inflammatory arthritis, non-English speakers, anyone with prior knee surgeries, or prisoners.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Participants complete the Brief Resiliency Scale questionnaire and receive pre-operative pain medication prescriptions
Surgery and Immediate Post-op
Participants undergo ACL reconstruction surgery and complete a Visual Analog Scale for pain assessment in the recovery room
Post-operative Treatment
Participants follow a prescribed pain medication regimen and maintain a pain diary for 6 weeks
Follow-up
Participants complete the Knee Injury and Osteoarthritis Outcome Score at 3 months and the Marx Activity Rating Scale at 6 months to assess knee function
What Are the Treatments Tested in This Trial?
Interventions
- Adductor Canal Nerve Block
- Ropivacaine injection
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor